Go Pro

U.S. Physical Therapy (NYSE:USPH) Shares Cross Above 200-Day Moving Average - Here's Why

U.S. Physical Therapy logo with Healthcare background
Image from MarketBeat Media, LLC.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $73.09 and traded as high as $83.35. U.S. Physical Therapy shares last traded at $82.28, with a volume of 169,774 shares.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on USPH shares. Citizens Jmp reaffirmed a "market outperform" rating and set a $98.00 price target on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. JPMorgan Chase & Co. increased their price objective on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the company an "overweight" rating in a research note on Friday, September 11th. Zacks Research upgraded shares of U.S. Physical Therapy from a "strong sell" rating to a "hold" rating in a research report on Wednesday, May 27th. Barrington Research lifted their target price on U.S. Physical Therapy from $90.00 to $98.00 and gave the company an "outperform" rating in a report on Monday, August 10th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 26th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, U.S. Physical Therapy presently has a consensus rating of "Moderate Buy" and an average target price of $98.25.

Get Our Latest Analysis on U.S. Physical Therapy

U.S. Physical Therapy Trading Down 0.2%

The company has a market cap of $1.23 billion, a P/E ratio of 484.03, a P/E/G ratio of 2.10 and a beta of 1.13. The business has a fifty day simple moving average of $78.26 and a 200 day simple moving average of $73.09. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.27 and a current ratio of 1.27.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.75 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.06). The business had revenue of $214.06 million for the quarter, compared to the consensus estimate of $211.36 million. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The firm's revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.81 EPS. Analysts anticipate that U.S. Physical Therapy, Inc. will post 2.89 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 11th. Stockholders of record on Friday, August 21st were issued a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Friday, August 21st. U.S. Physical Therapy's dividend payout ratio (DPR) is 1,082.35%.

Hedge Funds Weigh In On U.S. Physical Therapy

Large investors have recently bought and sold shares of the stock. Hantz Financial Services Inc. lifted its position in U.S. Physical Therapy by 56.4% in the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company's stock worth $29,000 after purchasing an additional 132 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of U.S. Physical Therapy during the 2nd quarter valued at $30,000. Integrated Wealth Concepts LLC acquired a new position in shares of U.S. Physical Therapy during the 2nd quarter valued at $33,000. Parallel Advisors LLC raised its stake in shares of U.S. Physical Therapy by 75.2% in the 1st quarter. Parallel Advisors LLC now owns 785 shares of the company's stock worth $59,000 after buying an additional 337 shares in the last quarter. Finally, Huntington National Bank raised its stake in shares of U.S. Physical Therapy by 15.4% in the 4th quarter. Huntington National Bank now owns 1,052 shares of the company's stock worth $82,000 after buying an additional 140 shares in the last quarter.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc is a healthcare company that operates outpatient physical therapy clinics and manages physical therapy practices throughout the United States. Its clinics provide rehabilitation services for patients recovering from injuries, surgeries, illnesses and chronic conditions, with treatment commonly focused on restoring mobility, strength and function.

The company operates both physical therapy facilities and physical therapy management partnerships. In addition to traditional outpatient rehabilitation, its services include sports medicine, workers' compensation care and related programs designed to help employers prevent and manage workplace injuries.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines